[
    [
        {
            "time": "2021-06-01",
            "original_text": "RPT-After early COVID-19 response, Australia stuck in vaccine slow lane",
            "features": {
                "keywords": [
                    "COVID-19",
                    "vaccine",
                    "slow lane"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false"
            },
            "scores": {
                "Correlation": 3,
                "Sentiment": 2,
                "Importance": 7,
                "Impact": 4,
                "Duration": 8,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-07-05",
            "original_text": "Delta variant sparks concerns, future mutations remain a threat",
            "features": {
                "keywords": [
                    "Delta variant",
                    "concerns",
                    "mutations",
                    "threat"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false"
            },
            "scores": {
                "Correlation": 4,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 5,
                "Duration": 9,
                "Entity_Density": 1,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-06-14",
            "original_text": "Why Spero Therapeutics Stock Is Up 15% Today",
            "features": {
                "keywords": [
                    "Spero Therapeutics",
                    "Stock",
                    "Up",
                    "15%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 7,
                "Duration": 3,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2021-06-23",
            "original_text": "Is Pfizer Stock A Buy Or Sell As Officials Examine Vaccine-Linked Heart Condition?",
            "features": {
                "keywords": [
                    "Pfizer",
                    "Stock",
                    "Buy",
                    "Sell",
                    "Vaccine-Linked",
                    "Heart Condition"
                ],
                "sentiment_score": -0.4,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-07-01",
            "original_text": "3 Big Drugmakers Likely to be in Focus in Second Half of 2021",
            "features": {
                "keywords": [
                    "Drugmakers",
                    "Focus",
                    "Second Half",
                    "2021"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-06-28",
            "original_text": "The Zacks Analyst Blog Highlights: Pfizer, Qualcomm, Philip Morris International, Freeport-McMoRan and FedEx",
            "features": {
                "keywords": [
                    "Zacks",
                    "Analyst",
                    "Blog",
                    "Pfizer",
                    "Qualcomm",
                    "Philip Morris International",
                    "Freeport-McMoRan",
                    "FedEx"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "technology",
                    "consumer goods",
                    "materials",
                    "transportation"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-06-15",
            "original_text": "ACHV: Target Up On Longer Patent Life",
            "features": {
                "keywords": [
                    "ACHV",
                    "Target",
                    "Up",
                    "Longer",
                    "Patent",
                    "Life"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2021-06-02",
            "original_text": "REFILE-After early COVID-19 response, Australia stuck in vaccine slow lane",
            "features": {
                "keywords": [
                    "COVID-19",
                    "vaccine",
                    "slow lane"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false"
            },
            "scores": {
                "Correlation": 3,
                "Sentiment": 2,
                "Importance": 7,
                "Impact": 4,
                "Duration": 8,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-06-16",
            "original_text": "CureVac Slumps After Confirming COVID Vaccine Candidate Only 48% Effective",
            "features": {
                "keywords": [
                    "CureVac",
                    "Slumps",
                    "COVID",
                    "Vaccine",
                    "Candidate",
                    "48%",
                    "Effective"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        }
    ]
]